Adult rats were anesthetized and subjected to sciatic nerve crush, and axoplasm was obtained from nerves dissected at the indicated times postlesion. Aliquots (40 g) of axoplasm were analyzed by Western blot and quantified in reference to the level of vimentin and peripherin at 6 hr. Calpeptin (100 M), cycloheximide (10 g/ml), or actinomycin-D (5 g/ml) was applied to the nerve by injection concomitantly with the injury. β-tubulin was used to confirm equal loading. The quantification is in percent of protein levels at 6 hr postlesion (averages ± standard deviation; n = 3). examined the expression of vimentin or peripherin in jured nerve. Vimentin was observed to coprecipitate with dynein in increasing amounts with time after injury the sciatic nerve and DRG and observed vimentin immunostaining in the cell body and processes of ap- (Figure 2A ). In contrast, peripherin was not found in any of the precipitates, despite the high levels of peripherin proximately 60% of adult wild-type NFH-positive sensory neurons in culture ( Figure 1B) . A corresponding found in axoplasm at these time points (see Figure 1C) . The increased amounts of vimentin coprecipitating with fraction of vimentin null neurons stained positively for β-galactosidase (β-gal), thus confirming expression of dynein over time after injury are a direct consequence of the increasing amounts of vimentin and importin β, the vimentin locus after lesion. We then examined occurrence of both IFs in sciatic nerve axoplasm in vivo, since analyses of precipitated over input levels revealed similar pull-down efficiency at the different time after verifying purity of the axoplasm preparations by lack of immunoreactivity for S100 and RCC1 (data not points (data not shown). As reported previously, importin α4 was found in the complex in both uninjured and shown), as well as lack of other glial or nuclear markers (see Figure S1 in the Supplemental Data available with lesioned nerve, while importin β levels increased in the coprecipitate after injury (Figure 2A ). Reciprocal coimthis article online). Little or no IF was found in axoplasm before injury, but within 30 min of a lesion we observed munoprecipitations with an antibody directed against vimentin revealed increasing amounts of dynein, importhe appearance of soluble forms of both vimentin and peripherin ( Figure 1C) . Levels of these proteins intin α, and importin β with time after injury ( Figure 2B ). Does vimentin access the NLS binding site in the comcreased during 8 hr following injury, and it was possible to block the increase by injecting the nerve with cycloplex? We addressed this issue by conducting coprecipitation experiments of dynein with vimentin in the heximide (CHX), an inhibitor of translation, but not with actinomycin-D (ACTD), an inhibitor of transcription. The presence of excess NLS peptide or reverse-NLS peptide as control. As shown in Figure 2C , the interaction lower molecular masses of both IFs were lost upon treatment of the nerve with the calpain inhibitor calpepof vimentin with dynein is not competed by excess NLS. Silver staining of 2D-PAGE from such pull-downs tin. Addition of calpeptin to already extracted axoplasm had no effect on the vimentin pattern observed (data revealed other protein spots that are displaced from the dynein complex by NLS peptide (data not shown). not shown). Thus, soluble forms of vimentin and peripherin are produced in injured sciatic nerve axoplasm by Moreover, vimentin coprecipitates from axoplasm together with the importins in NLS pull-downs (Figure a combination of local translation and calpain cleavage activity. 2D), indicating that a vimentin-importin interaction cannot be mediated via the NLS binding site. A number of We then examined coimmunoprecipitation of vimentin or peripherin with the dynein motor complex in innonclassical importin cargoes undergo nuclear uptake by direct binding to importin β (Harel and Forbes, 2004). ing amounts of vimentin but not peripherin ( Figure 3C ). We then examined retrograde transport of vimentin and We therefore tested for a direct interaction of vimentin with importin β by in vitro coprecipitation of vimentin pErk after sciatic nerve lesion in vivo. Crushed nerves from adult rats at increasing times after lesion were diwith a GST-importin β fusion protein. Purified recombinant vimentin was readily pulled down with GST-imporvided into consecutive segments as shown in Figure  4A . Axoplasm from each segment was subjected to dytin β but did not precipitate with GST alone ( Figure 2E ). Finally, GST-importin β was incubated with axoplasm nein immunoprecipitation, and precipitates were then analyzed by Western blot for presence of vimentin and from different times after lesion, and Western blots of pull-downs were probed for both vimentin and periphpErk. Both molecules moved retrogradely together with dynein over the time course of the experiment, arriving erin. As shown in Figure 2F , increasing amounts of vimentin were found in the pull-downs in correlation with at the L4/L5 DRGs approximately 20 hr after the lesion. Interestingly, vimentin remained associated with dynein time after lesion, whereas peripherin could not be detected at any of the time points examined. up to the 24 hr time point in the DRG, whereas the pErk was not found in the complex shortly after arrival in Having established that soluble forms of vimentin interact with the importin-dynein retrograde complex afthe ganglia ( Figure 4A) Figure 4B ). tion of MAP kinases in lesioned rat sciatic nerve and observed phosphorylation of axoplasmic Erk1/2 within We verified that the later phosphorylation event indeed occurs in neurons by immunostaining of L4/L5 ganglion 30 min and lasting at least 8 hr after injury ( Figure 3A) . Immunoprecipitation of either vimentin or dynein from sections for NFH and pElk1. As shown in the right panel of Figure 4B , phosphorylated Elk1 is concentrated in axoplasm revealed coprecipitation of pErk increasing with time after lesion ( Figure 3B ). Incubation of recomnuclei of NFH-positive neuronal cell bodies 24 hr after sciatic nerve lesion. binant GST-pErk2 with axoplasm from different time points after lesion revealed coprecipitation of increas-
The discrepancy between dissociation times of vi- interactions and found that vimentin binding to pErk2 mentin and pErk from the dynein complex upon arrival at the ganglia suggested differential regulation of these in vitro was calcium dependent, increasing at calcium concentrations of up to 1 M ( Figure 5A ). In contrast, two interactions. Nerve injury is known to cause a significant increase in intracellular calcium levels in axons changing calcium concentrations had little or no effect on the vimentin-importin β interaction. Similar experi-(Mandolesi et al., 2004). We therefore tested the effects of calcium on the pErk-vimentin and vimentin-importin ments with nonphosphorylated Erk2 revealed that bind-ing of nonphosphorylated Erk to vimentin is reduced at high calcium concentrations (data not shown). Therefore, another possible explanation for the apparent dissociation of pErk in the cell body might be dephosphorylation of the kinase. We examined this issue by testing the effects of increasing concentrations of vimentin on Erk phosphorylation in the presence of alkaline phosphatases (APs) or of sciatic nerve axoplasm. Strikingly, vimentin levels in the range of 3-fold to 6-fold molar ratio of vimentin to pErk provided almost complete in vitro protection of pErk2 from the phosphatases, while similar levels of neurofilament (NF) had no effect ( Figure 5B ). The protection of pErk by vimentin was specific, as identical concentrations of vimentin had no effect on hydrolysis of p-nitrophenyl phosphate (pNPP) by AP (data not shown). The calcium dependence of pErk binding to vimentin prompted us to examine if the in vitro phosphatase protection provided by vimentin could also be modulated by calcium. As shown in Figure 5C , vimentin protected pErk2 from dephosphorylation in vitro in a calcium-dependent manner, and in the same range of calcium concentrations that support pErk-vimentin binding. The data described thus far indicate that soluble forms of vimentin interact with the importin-dynein retrograde complex in injured rat sciatic nerve and thereby enable transportation of pErk from the lesion site to activate substrates such as Elk1 in neuronal cell bodies. We tested these findings by comparing immunoprecipitates of dynein from sciatic nerve axoplasm of wildtype and vimentin −/− mice. The pErks coprecipitated with dynein in injury axoplasm from wild-type mice but not from vimentin nulls ( Figure 6A ). Injury-induced Erk phosphorylation was similar in wild-type and vimentin −/− axoplasm; thus, the specific difference was the lack of interaction of pErk with the dynein complex in vimentin null animals. We then examined retrograde accumulation of p-Erk in a lesion-ligation paradigm in sciatic nerves of wild-type versus vimentin null mice. As shown in Figure 6B , pErk accumulated retrogradely at Figures 7C and 7D) . A simoriginally destined to express vimentin) with similar cells from the same ganglia that did not express β-gal (Figilar effect was observed in neurons from vimentin null mice that did not express β-gal. In contrast, β-gal-posiures 7A, 7B, and S2A). We examined the capacity of calpain-treated vimentin for polymerization by compartive neurons from vimentin −/− DRG did not extend longer neurites as a result of the conditioning crush ing pelleted versus soluble vimentin after ultracentrifugation ( Figure S2B ) and by comparative observation of ( Figures 7C and 7D) . Thus, both in vitro and in vivo, a vimentin-mediated signal facilitates the regenerative vimentin filaments by electron microscopy ( Figure S2C ). Both assays showed that calpain-treated vimentin was response of DRG neurons. In order to ask whether the vimentin-mediated signal not capable of polymerizing into filamentous structures; thus, the outgrowth rescue activity obtained by is pErk, we tested a series of synthetic peptides designed to mimic surface-exposed regions of Erk for trituration of the protein cannot be due to cytoskeletal roles of vimentin.
their capacity to interfere with pErk-vimentin binding ( Figure 7E ). Out of five peptides examined in this way, a DRG neurons undergo a transcription-dependent ). Each row includes two panels with predominantly vimentin-or β-galpositive cells and two panels with cells predominantly negative for these markers. The third (lower) row shows vimentin −/− neurons triturated with calpain-cleaved vimentin (6.7 g per ganglion) before plating. Quantification of three independent experiments is shown in (B), measuring at least 250 cells per experiment (average ± standard error of mean). Significant differences are revealed in neurite outgrowth between the vimentin null and wild-type neurons in the total population (p < 0.05). These differences are even more pronounced when comparing vimentin-positive to β-gal-positive neurons (p < 0.01), while there was no difference between wildtype vimentin-negative and vimentin null β-gal-negative cells. Trituration of calpaintreated vimentin to vimentin null neurons before plating enhanced the outgrowth of β-gal-positive cells and had no effect on cells that did not express the β-gal marker. Vimentin uptake after trituration was verified by immunostaining, and we analyzed only those cultures in which over 50% of the cells contained vimentin 3 hr after trituration. Trituration of calpain-treated neurofilament had no effect, and calpain-treated vimentin was found to be incapable of polymerization (Figure S2) . Scale bar, 50 m.
(C and D) Effects of sciatic nerve conditional lesion in vimentin
−/− mice. Sciatic nerves were crushed as described, and L4/L5 DRG neurons were cultured 3 days after the conditioning lesion. Neurons were fixed after 18 hr in culture and stained, and neurite outgrowth was measured. Wild-type neurons and vimentin null neurons negative for β-gal revealed accelerated neurite outgrowth after a conditioning crush (>100 neurons measured from two independent experiments; p < 0.01), whereas no change was observed in vimentin null β-gal-positive cells (250 neurons measured from two independent experiments; average ± standard error of mean). Scale bar, 100 m.
(E) Effects of five Erk-derived synthetic peptides (sequences shown on the left) on the interaction of vimentin with pErk. Five different peptides were incubated with vimentin (20:1 molar ratio) in PBS for 2 hr at 37°C, followed by GST-pErk pull-down. A single peptide designated Erk89 clearly inhibits pErk-vimentin binding, and the inhibition was shown to be concentration dependent. This experiment was repeated three times with similar results. (F and G) Effects of the MEK inhibitor UO126 and the Erk89 peptide on conditioning lesion responses in adult rat DRG neurons. Sciatic nerves
were injected with 10 M UO126 or 250 g of Erk89 or Erk312 peptides, concomitantly with a conditioning crush injury. Five days after the lesion, L4/L5 DRG neurons were cultured in vitro for 18 hr, fixed, and stained for NFH before measurement of neurite outgrowth. Both the percentage of sprouting neurons (n = 300 for each treatment; p < 0.01) and the neurite length in those that did sprout (n > 60 for each treatment; p < 0.05) were significantly reduced by UO126 or Erk89, whereas the Erk312 peptide had no effect. The experiment was repeated three times with two animals for each treatment, totaling six independent animal assays for each treatment (average ± standard error of mean). Scale bar, 100 m. (H) Recovery of sensory responses after lesion of the sciatic nerve in vivo. Wild-type and vimentin null mice (14 animals in each group) underwent sciatic nerve lesion and were then monitored daily for up to 30 days postlesion. At each monitoring session, the animal's response to toe pinch was tested for each individual digit, and the response was plotted as percent of responding digits. There was an immediate and essentially complete cessation of response in both groups of animals immediately after the lesion, with a clear difference in recovery kinetics between wild-type and vimentin null animals. GAP43 immunostaining was performed to compare (AU, arbitrary units) regeneration in longitudinal sections totaling 1 cm nerve length adjacent to the lesion site. This analysis revealed significant differences between wild-type and vimentin null nerves 6 days after lesion (average ± standard deviation). Scale bar, 100 m.
single peptide designated Erk89 (numbering is the first tides on the conditioning lesion response in adult rats.
In parallel experiments, we also examined the effects residue of the peptide as found in human Erk2) was found to inhibit vimentin-pErk binding in a concentraof the MEK inhibitor UO126. The peptides or the inhibitor were injected into sciatic nerve concomitantly with tion-dependent manner. We therefore tested the effects of the Erk89 in comparison with another one of the pepa conditioning sciatic nerve crush, and outgrowth of Figure S1 .
in SDS-PAGE sample buffer before loading on gels for Western blot DRG cultures from adult animals were as previously described analyses. For coimmunoprecipitation in the presence of competi- (Hanz et al., 2003) . Vimentin trituration into DRGs was carried out tors, 2 M NLS or reverse-NLS peptides were added to the axoby introducing 100 g of vimentin to the trituration medium for 15 plasm for overnight incubation at 4°C. For direct pull-downs, GSTganglia. Vimentin was prepared for trituration by cleavage with calpERK (0.5 g) or importin β (1 g) were equilibrated in PBS or NTB pain (100 U; 2 hr). In vivo conditioning sciatic nerve lesions were and added to 500 g aliquots of axoplasm from different postlesion carried out as described by Hanz et al. (2003) . For tests of introtimes. Direct interactions were tested in vitro by mixing 0.1 g reduced substances, sciatic nerves were injected concomitantly with combinant Syrian hamster vimentin or NF (Cytoskeleton Inc., Denthe crush with the MEK inhibitor UO126 (Biomol; 10 M), the Erk89 ver, CO) to GST-pERK or GST-importin β and incubated for 2 hr at or Erk312 peptides (250 g), or calpeptin (Calbiochem; 100 M).
37°C. All pull-downs were washed twice with 0.2 M NaCl in PBS or L4/L5 DRG neurons were cultured 3-5 days after the conditioning NTB and twice again with PBS or NTB before elution in SDS-PAGE lesion. Neurons were fixed after 18 hr in culture and stained with sample buffer for loading on gels. NFH, and the length of the longest axon per neuron was measured.
In vivo regeneration and recovery of sensory function was tested
Phosphatase Protection Assay on wild-type and vimentin null mice following sciatic nerve crush.
His-Imp-β (2 g) was incubated with GST-pERK (0.1 g) and with Mice were monitored daily for foot withdrawal in response to toe 0-2 g vimentin or NF for 2 hr at 37°C. AP (2 units; Roche, Mannpinch of each individual digit with forceps, scored as the percenheim, Germany) or axoplasm from injured nerve (100 g) was then tage of responding digits. Longitudinal sections on injured nerve added for an additional 30 min. Complexes were purified over GST were carried out at designated times and immunostained with antibeads followed by Western blot analysis for pERK. AP activity was GAP43 rabbit polyclonal AB5220 (Chemicon). All animal experiverified with the synthetic substrate pNPP (Sigma S0942) dissolved mentation was under the supervision of the Weizmann Institute Inin 0.1 M glycine buffer (0.1 M glycine, 1 mM MgCl 2 , 1 mM ZnCl 2 ; stitutional Animal Care and Use Committee. pH 10.4) for a stock solution of 1 mg/ml. One unit AP was added to a reaction mixture consisting of 1 g pNPP with 2 g vimentin Antibodies, Western Blots, and Immunofluorescence or NF in Tris buffer (pH 7.5) and incubated for 5, 15, and 30 min The following antibodies were from Chemicon International (Temecbefore stopping the reaction with 3 N NaOH. The yellow hydrolysis ula, CA): vimentin monoclonal clone V9 MAB3400; vimentin polyproduct was quantified spectrophotometrically at 405 nm. clonal AB1620; peripherin polyclonal AB1530; dynein 74 kDa intermediate chain monoclonal MAB1618; β-gal monoclonal AB1802; β-gal polyclonal AB1211; NFH polyclonal AB1989; CNPase moRetrograde Movement Rat sciatic nerves were crushed and dissected out at increasing noclonal MAB326. The following antibodies were from Sigma (Rehovot, Israel): NFH clone N52 monoclonal; Erk polyclonal M5670; times after lesion (0-24 hr). Dissected nerves were divided into consecutive segments of about 10 mm each before extraction of axodoubly phosphorylated Erk monoclonal M8159; GFAP clone G-A-5. The importin β monoclonal antibody 3E9 MA3-070 was from Affinity plasm. From each segment, 300 g axoplasm was immunoprecipitated with the dynein antibody, and precipitates were analyzed by Bioreagents (Golden, CO); β-tubulin polyclonal SC 9104 and lamin A/C N18 SC 6215 were from Santa Cruz (Santa Cruz, CA); for Western blot for vimentin and pErk. Followup experiments in mouse were conducted with wild-type or vimentin −/− sciatic nerves, pElk-1 we used monoclonal 9186 from Cell Signaling (Beverley, MA); and anti-importin α4 was a kind gift from Dr. Karsten Weis crushed and ligated as described. At designated times, the nerves were dissected, fixed, and sectioned longitudinally over the ligation (UC Berkeley). HRP-conjugated secondary antibodies were from
